Summary. This study was conducted to determine whether intrauterine infusion of recombinant bovine interferon-\g=a\I1(rboIFN-\g=a\I1), which has 70% sequence identity to bovine trophoblast protein-1, will prevent regression of corpora lutea anticipated to have a short lifespan.Twenty-six beef cows in good body condition were allotted to four treatment groups at parturition in a 2 \m=x\ 2 factorial design. Treatments were: group 1, saline; group 2, rboIFN-\g=a\I1;group 3, norgestomet\p=n-\saline; and group 4, norgestomet\p=n-\rboIFN\x=req-\ \g=a\I1.Norgestomet implants were inserted on days 21\p=n-\24 postpartum and removed 9 days later (before injection of human chorionic gonadotrophin (hCG) ). Ovulation was induced 30 to 33 days postpartum with 5000 or 10 000 iuhCG. Groups 1 (n = 7) and 3 (n = 5) were given intrauterine infusions (rectocervical approach) twice daily with saline on days 1\p=n-\12 or 13\p=n-\24 after hCG injection, respectively. Cows allotted to groups 2 (n = 8) and 4 (n = 6) were given intrauterine infusions (rectocervical approach) of 2 mg rboIFN-\g=a\I1 twice daily on days 1\p=n-\12 or 13\p=n-\24 after hCG injection, respectively.Treatment with both norgestomet and rboIFN-\g=a\I1delayed (P < 0\m=.\01)luteolysis.Lengths of luteal phases (days; mean \ m=+-\ sem) were 8\m=.\4\ m=+-\0\m=.\7 (group 1, saline), 12\m=.\1\ m=+-\ 1\m=.\0 (group 2, rboIFN-\g=a\I1), 18\m=.\6 \ m=+-\ 1\m=.\3 (group 3, norgestomet\p=n-\saline and 20\m=.\8\m=+-\1\ m=. \ 2 (group 4, norgestomet\p=n-\rboIFN-\g=a\I1). Concentration of progesterone in serum was similar among all groups the first 6 days following hCG-induced ovulation, but differed (P < 0\m=.\01) thereafter. Mean concentration of progesterone was lower (P < 0\m=.\01) in saline-treated cows (group 1) from days 8 to 13 than in cows infused with rboIFN-\g=a\I1 or pretreated with norgestomet. In summary, intrauterine infusion of rboIFN-\g=a\I1 delayed luteolysis of corpora lutea a n t i c i p a t e dto have a short lifespan.